Abeona Therapeutics(ABEO)

7.93 0.17 2.1907%

今开：7.76昨收：7.76
最高：8.45 最低：7.73
涨停价：0.0跌停价：0.0
总市值：2.16925443E8

Abeona Therapeutics的热门讨论

持股变动声明

Abeona Therapeutics(ABEO)2023-09-30 05:15

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-23-034858  Size: 5 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)2023-09-30 05:35

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-23-034904  Size: 5 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)2023-09-30 04:45

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-23-034856  Size: 5 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)2023-09-30 04:55

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-23-034855  Size: 5 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)2023-09-30 05:35

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-23-034916  Size: 5 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)2023-09-30 05:15

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-23-034857  Size: 5 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)2023-09-30 05:25

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-23-034903  Size: 5 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)2023-09-23 04:15

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-23-033446  Size: 4 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)2023-09-23 04:15

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-23-033448  Size: 5 KB 网页链接查看全文

持股变动声明

Abeona Therapeutics(ABEO)2023-09-19 21:05

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-23-033000  Size: 4 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

Abeona Therapeutics的最新讨论

产业链观察2023-11-27 22:14

#药闻简讯# $Abeona Therapeutics(ABEO)$ FDA接受并授予Pz-cel BLA的优先审评。
PDUFA 05/25/24.
FDA目前不打算举办AdComm查看全文

SeekingBiotech2023-07-29 20:29

ABEO announced that it has completed the submission of the briefing package to the FDA for its pre-Biologics License Application (BLA) meeting in August 2023$Abeona Therapeutics(ABEO)$查看全文

牛唐2023-07-10 20:22

医药板块速评（2022.07.07）
1、多个7月有数据发布的BIotech股价启动，哪些有配置机会？
2、$Abeona Therapeutics(ABEO)、$居里(CRIS)纷纷增发，是否有上车机会？
3、$Wolfspeed(WOLF)$ 、$ETFMG Alternative Harvest ETF(MJ)$ 、$油气服务ETF-Market Vectors(OIH)$ 等异动，后续走势...查看全文

SeekingBiotech2023-06-09 22:39

$Abeona Therapeutics(ABEO)$
基因治疗候选新药。需要补充材料。
营养不良性大疱性表皮松解症（DEB）（包括隐性营养不良性大疱性表皮松解症-RDEB）
Abeona Therapeutics Announces Regulatory Update on Biologics License Application (BLA) for EB-101查看全文

牛唐2022-10-11 21:37

$Abeona Therapeutics(ABEO)$ 40%+的收益，$蔚来(NIO)$ $拼多多(PDD)$查看全文

骑猪看花2022-07-01 21:04

$Abeona Therapeutics(ABEO)$ 25股合一股 操 真牛 渣都不剩了查看全文

chuminhua2022-05-18 14:58

5月17日， Ultragenyx Pharmaceutical 已就 Abeona Therapeutics 治疗 A 型Sanfilippo 综合征 （ 黏多糖贮积症 III型，MPS IIIA ）在研基因疗法 ABO-102的全球权利达成独家许可协议。 Ultragenyx 将承担 ABO-102（现称为 UX111）的开发责任，Abeona 有资格获得高达净销售额 10% 的分层特许权使用费...查看全文

骑猪看花2021-12-17 09:00

$Abeona Therapeutics(ABEO)$ 完了 芭比Q了[吐血]查看全文

战马恋歌2021-12-17 08:47

$Abeona Therapeutics(ABEO)$ 毛票的路上一去不返[吐血]查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Abeona Therapeutics的新闻

Abeona Therapeutics(ABEO.US)基因校正表皮获FDA优先审评资格

智通财经APP获悉，11月27日，Abeona Therapeutics(ABEO.US)宣布，美国FDA已接受其在研疗法pz-cel(prademagene zamikeracel，EB-101)的生物制品许可申请(BLA)，并授予优先审评资格，该疗法是一款自体、COL7A1基因校正表皮片，用于隐性... 网页链接

Abeona Therapeutics的公告

股东委托书协议

$Abeona Therapeutics(ABEO)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-010421  Act: 34  Size: 1 MB 网页链接

当期报告

$Abeona Therapeutics(ABEO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-010206  Act: 34  Size: 292 KB 网页链接

年度财报

$Abeona Therapeutics(ABEO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-010190  Act: 34  Size: 8 MB 网页链接

持股变动声明

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-010132  Size: 5 KB 网页链接

持股变动声明

$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-009682  Size: 5 KB 网页链接

超过5%股东持股披露「修订」

$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023895  Act: 34  Size: 59 KB 网页链接

超过5%股东持股披露「修订」

$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000200  Act: 34  Size: 47 KB 网页链接

超过5%股东持股披露「修订」

$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001713  Act: 34  Size: 62 KB 网页链接

超过5%股东持股披露「修订」

$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-001247  Act: 34  Size: 91 KB 网页链接

超过5%股东持股披露「修订」

$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193805-24-000176  Act: 34  Size: 104 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51